Cardiotoxicity and Cardiovascular Biomarkers in Patients With Breast Cancer: Data From the GeparOcto‐GBG 84 Trial

Cardiotoxicity and Cardiovascular Biomarkers in Patients With Breast Cancer: Data From the GeparOcto‐GBG 84 Trial

Background Patients with breast cancer can be affected by cardiotoxic reactions through cancer therapies. Cardiac biomarkers, like NT‐proBNP (N‐terminal pro‐B‐type natriuretic peptide) and high‐sensitivity cardiac troponin T, might have predictive value. Methods and Results Echocardiography, ECG, he...

Full description

Bibliographic Details
Main Authors: Alexandra Maria Rüger, Andreas Schneeweiss, Sabine Seiler, Hans Tesch, Marion van Mackelenbergh, Frederik Marmé, Kristina Lübbe, Bruno Sinn, Thomas Karn, Elmar Stickeler, Volkmar Müller, Christian Schem, Carsten Denkert, Peter A. Fasching, Valentina Nekljudova, Tania Garfias‐Macedo, Gerd Hasenfuß, Wilhelm Haverkamp, Sibylle Loibl, Stephan von Haehling
Format: Article
Language:English
Published: Wiley 2020-12-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
biomarker
breast cancer
cardio‐oncology
cardiotoxicity
left ventricular ejection fraction
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.120.018143

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.120.018143

Similar Items